2024-07-01 SC702374 2025-06-30 SC702374 2024-07-01 2025-06-30 SC702374 2024-06-30 SC702374 2023-07-01 2024-06-30 SC702374 uk-core:WithinOneYear 2024-06-30 SC702374 uk-core:WithinOneYear 2025-06-30 SC702374 uk-core:ShareCapital 2025-06-30 SC702374 uk-core:ShareCapital 2024-06-30 SC702374 uk-core:RetainedEarningsAccumulatedLosses 2025-06-30 SC702374 uk-core:RetainedEarningsAccumulatedLosses 2024-06-30 SC702374 uk-bus:Director1 2024-07-01 2025-06-30 SC702374 uk-core:WithinOneYear 2024-07-01 2025-06-30 iso4217:GBP xbrli:pure SC702374 uk-bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 SC702374 uk-bus:FRS102 2024-07-01 2025-06-30 SC702374 uk-bus:FilletedAccounts 2024-07-01 2025-06-30 SC702374 uk-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30
GMP Medical Licensing Ltd
Registered Number:SC702374
For the year ended 30 June 2025
Scotland
Unaudited Financial Statements
2
For the year ended 30 June 2025
GMP Medical Licensing Ltd
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
SC702374
As at 30 June 2025
GMP Medical Licensing Ltd
Statement of Financial Position
£
£
2024
2025
Notes
Fixed assets
Property, plant and equipment
1,477
1,969
2
1,477
1,969
Current assets
7,196
Cash and cash equivalents
15,240
15,240
7,196
Trade and other payables: amounts falling due within one
year
(22,566)
(26,500)
4
(15,370)
(11,260)
Net current liabilities
Total assets less current liabilities
(9,783)
(13,401)
(9,783)
Net liabilities
(13,401)
Capital and reserves
Called up share capital
2
2
Retained earnings
(9,785)
(13,403)
(9,783)
(13,401)
Shareholders' funds
For the year ended 30 June 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Santiago Giavedoni Director
These financial statements were approved and authorised for issue by the Board on 12 November 2025 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 30 June 2025
GMP Medical Licensing Ltd
Notes to the Financial Statements
Statutory Information
GMP Medical Licensing Ltd is a private limited company, limited by shares, domiciled in Scotland, registration number
SC702374.
Registered address:
76/3F2 Comiston Road
Edinburgh
EH10 5QJ
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
2. Property, plant and equipment
Computer
Equipment
£
Cost or
valuation
At 01 July 2024
4,000
At 30 June 2025
4,000
Provision for depreciation and impairment
At 01 July 2024
2,031
Charge for year
492
At 30 June 2025
2,523
At 30 June 2025
Net book value
1,477
At 30 June 2024
1,969
3. Trade and other receivables
Short-term debtors are measured at fair value at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and measured subsequently at amortised cost using the effective interest method, less any impairment.
2 of 3
5
For the year ended 30 June 2025
GMP Medical Licensing Ltd
Notes to the Financial Statements Continued
4. Trade and other payables: amounts falling due within one year
2024
2025
£
£
Taxation and social security
547
-
Other creditors
25,953
22,566
26,500
22,566
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
5. Average number of persons employed
During the year the average number of employees was 0
3 of 3